Human Cardiovascular ELISA Kits
Human APLN (Apelin) ELISA Kit (HUES01662)
- SKU:
- HUES01662
- Product Type:
- ELISA Kit
- Size:
- 96 Assays
- Uniprot:
- Q9ULZ1
- Sensitivity:
- 37.5pg/mL
- Range:
- 62.5-4000pg/mL
- ELISA Type:
- Competitive
- Synonyms:
- APEL, XNPEP2
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Cardiovascular
Description
Assay type: | Competitive-ELISA |
Format: | 96T |
Assay time: | 2.5h |
Reactivity: | Human |
Detection Method: | Colormetric |
Detection Range: | 62.50-4000 pg/mL |
Sensitivity: | 37.50 pg/mL |
Sample Volume: | 50µL |
Sample Type: | Serum, plasma and other biological fluids |
Specificity: | This kit recognizes Human APLN in samples. No significant cross-reactivity or interference between Human APLN and analogues was observed. |
This ELISA kit uses Competitive-ELISA as the method. The microtiter plate provided in this kit has been pre-coated with Human APLN. During the reaction, Human APLN in the sample or standard competes with a fixed amount of Human APLN on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Human APLN. Excess conjugate and unbound sample or standard are washed from the plate, and Avidin conjugated to Horseradish Peroxidase (HRP) are added to each microplate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by adding Stop Solution and the color change is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Human APLN in the samples is then determined by comparing the OD of the samples to the standard curve.
UniProt Protein Function: | apelin: Endogenous ligand for APJ, an alternative coreceptor with CD4 for HIV-1 infection. Inhibits HIV-1 entry in cells coexpressing CD4 and APJ. Apelin-36 has a greater inhibitory activity on HIV infection than other synthetic apelin derivatives. The oral intake in the colostrum and the milk could have a role in the modulation of the immune responses in neonates. May also have a role in the central control of body fluid homeostasis by influencing AVP release and drinking behavior. Belongs to the apelin family. |
UniProt Protein Details: | Protein type:Secreted; Secreted, signal peptide Chromosomal Location of Human Ortholog: Xq25 Cellular Component: extracellular space; extracellular region Molecular Function:G-protein-coupled receptor binding; hormone activity; apelin receptor binding; receptor binding Biological Process: lactation; immune response; signal transduction |
NCBI Summary: | This gene encodes a peptide that functions as an endogenous ligand for the G protein coupled receptor APJ. The encoded protein is synthesized as a prepropeptide that is processed into biologically active C-terminal fragments. The peptide fragments activate different tissue specific signaling pathways that regulate diverse biological functions including fluid homeostasis, cardiovascular function and insulin secretion. This protein also functions as a coreceptor for the human immunodeficiency virus 1. [provided by RefSeq, Feb 2010] |
UniProt Code: | Q9ULZ1 |
NCBI GenInfo Identifier: | 20137569 |
NCBI Gene ID: | 8862 |
NCBI Accession: | Q9ULZ1. 1 |
UniProt Secondary Accession: | Q9ULZ1,Q4VY08, Q8WU89, |
UniProt Related Accession: | Q9ULZ1 |
Molecular Weight: | 8,569 Da |
NCBI Full Name: | Apelin |
NCBI Synonym Full Names: | apelin |
NCBI Official Symbol: | APLN |
NCBI Official Synonym Symbols: | APEL; XNPEP2 |
NCBI Protein Information: | apelin; AGTRL1 ligand; APJ endogenous ligand |
UniProt Protein Name: | Apelin |
UniProt Synonym Protein Names: | APJ endogenous ligand |
UniProt Gene Name: | APLN |
UniProt Entry Name: | APEL_HUMAN |
As the OD values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration(pg/mL) | O.D | Average |
4000 | 0.372 0.388 | 0.38 |
2000 | 0.496 0.502 | 0.499 |
1000 | 0.711 0.695 | 0.703 |
500 | 0.999 1.015 | 1.007 |
250 | 1.384 1.38 | 1.382 |
125 | 1.748 1.746 | 1.747 |
62.50 | 2.029 2.033 | 2.031 |
0 | 2.431 2.435 | 2.433 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human APLN were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human APLN were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 197.40 | 537.10 | 1359.90 | 204.30 | 499.70 | 1350.70 |
Standard deviation | 11.10 | 31.70 | 50.30 | 11.00 | 26.00 | 56.70 |
C V (%) | 5.62 | 5.90 | 3.70 | 5.38 | 5.20 | 4.20 |
Recovery
The recovery of Human APLN spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 85-98 | 90 |
EDTA plasma (n=5) | 91-102 | 96 |
Cell culture media (n=5) | 89-100 | 95 |
Linearity
Samples were spiked with high concentrations of Human APLN and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 95-108 | 98-114 | 88-102 |
Average (%) | 100 | 105 | 94 | |
1:4 | Range (%) | 85-97 | 89-101 | 99-115 |
Average (%) | 90 | 95 | 105 | |
1:8 | Range (%) | 87-101 | 90-104 | 97-111 |
Average (%) | 94 | 97 | 102 | |
1:16 | Range (%) | 84-94 | 92-103 | 97-112 |
Average (%) | 89 | 97 | 103 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro ELISA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent | 1 vial, 10 mL | 4°C(shading light) |
Stop Solution | 1 vial, 10 mL | 4°C |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record their positions. It is recommended to measure each standard and sample in duplicate. Note: add all solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensure solutions do not foam when adding to the wells.
- Add 50 µL of Standard, Blank or Sample to their respective wells. The blank well is added with Sample / Standard dilution buffer.
- Immediately add 50 µL of Biotin-detection antibody working solution to each well.
- Cover with a plate seal and gently tap the plate to ensure thorough mixing. Incubate for 45minutes at 37 °C.
- Aspirate or decant the solution from the plate and add 350 µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100 µL of HRP Conjugate working solution to each well and over with a plate seal. Incubate for 30 minutes at 37 °C.
- Repeat the aspiration/wash process 5 times according to step 5.
- Add 90 µL of the Substrate reagent to each well and cover with a new plate seal. Incubatefor approximately 15 minutes at 37 °C and protect from light. The reaction time can beshortened or extended according to the colour change, but not by more than 30 minutes. Whenapparent gradient appears in standard wells, terminate the reaction.
- Stop: Add 50 µL of Stop Solution to each well (wells will develop a yellow color immediately). Note: Adding the stop solution should be done in the same order as the substrate solution.
- Determine the optical density (OD value) of each well immediately with a microplate readerset at 450 nm. In advance, preheat the instrument and set the testing parameters.